Product Availability Alert


HPS Pharmacies wish to advise that Aspen Pharmacare have given notice of an interruption to supply of:

Actiq® (fentanyl) lozenges
Dose: 200 and 400 microgram
ARTG: 91958 and 91600

This shortage is due to the late arrival of a shipment, and stocks are now exhausted. Normal supply will resume promptly following arrival and is expected before the end of March 2014.

Limited supplies of 600, 800, 1200, and 1600 microgram Actiq® (fentanyl) lozenges are still available.

Actiq® lozenges are indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving, and are tolerant to, opioid therapy for their underlying persistent cancer pain.

Please retain this notice in a prominent position, including other related business units as a reminder for all staff members until supply resumes.

Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or Aspen Customer Support on 1300 659 646.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates